Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3669 Target Snapshot

Glycogen synthase kinase-3 beta · SINGLE PROTEIN · Rattus norvegicus

36Compounds
11Assays
0Approved Drugs
29.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P18266. Use UniProt P18266 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P18266 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Glycogen synthase kinase-3 beta as ChEMBL target CHEMBL3669, mapped to UniProt P18266. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Glycogen synthase kinase-3 beta
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3669
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P18266
Glycogen synthase kinase-3 beta
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Glycogen synthase kinase-3 beta is the right protein anchor across sources, using UniProt P18266 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGlycogen synthase kinase-3 beta
UniProt AccessionP18266
Component TypeProtein
Sequence Length420 aa

Glycogen synthase kinase-3 beta

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Glycogen synthase kinase-3 beta, mapped to UniProt P18266. Sequence length is 420 aa.

Mapped IDP18266
Review nameGlycogen synthase kinase-3 beta
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Phase III
Assay Mix

Activity Type Distribution

IC5012.0
EC5017.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL50894 8.4 IC50 4.0 Preclinical
CHEMBL6291 8.17 IC50 6.8 Preclinical
CHEMBL361708 8.0 IC50 10.0 Preclinical
CHEMBL388978 7.82 IC50 15.0 Preclinical
CHEMBL336961 7.75 IC50 18.0 Preclinical
CHEMBL216543 7.66 IC50 22.0 Preclinical
CHEMBL296586 7.64 IC50 23.0 Preclinical
CHEMBL5280328 7.4 IC50 40.0 Preclinical
CHEMBL140 7.18 IC50 66.0 Clinical
CHEMBL323657 6.92 IC50 120.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
9
5.5
6
6.0
1
6.5
2
7.0
4
7.5
3
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

11
Total Assays
16
Tested Compounds
2
Assay Types
Binding — 9 assays, 13 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 4 3 6.7
single protein format 3 9 7.5
assay format 2 1 7.2
Functional — 2 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0
cell-based format 1 16 5.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine